SCHEMBL26458902

SCHEMBL26458902

O=C(O)C(Cc1ccccc1)N1C(=O)/C(=C\C=C\c2ccco2)SC1=S

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 13/20 1.00
▸ MEN1 O00255 9/20 1.00
▸ KMT2A Q03164 9/20 1.00
▸ POLB P06746 8/20 1.00
▸ L3MBTL1 Q9Y468 7/20 1.00
▸ USP2 O75604 7/20 1.00
▸ KDM4E B2RXH2 6/20 1.00
▸ RECQL P46063 6/20 1.00
▸ BLM P54132 5/20 1.00
▸ ALDH1A1 P00352 5/20 1.00
▸ THRB P10828 4/20 1.00
▸ TDP1 Q9NUW8 4/20 1.00
▸ PSMD14 O00487 1/20 1.00
▸ MMP2 P08253 1/20 1.00
▸ NSD2 O96028 3/20 0.79
▸ ALPL P05186 3/20 0.79
▸ APAF1 O14727 1/20 0.79
▸ SAE1 Q9UBE0 1/20 0.79
▸ UBA2 Q9UBT2 1/20 0.79
▸ DUSP3 P51452 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14680220 1.00 MAPT (1.00) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL18598496 0.91 MAPT (0.83) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL14680251 0.88 MAPT (0.78) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL14680229 0.81 MAPT (1.00) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL20705581 0.80 MAPT (0.67) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL19425501 0.79 DUSP3 (0.72) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL13894970 0.78 DUSP3 (0.71) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL5991599 0.78 MEN1 (0.75) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL19425506 0.78 DUSP3 (0.71) MAPTMEN1KMT2APOLBL3MBTL1
SCHEMBL20705618 0.77 MAPT (0.63) MAPTMEN1KMT2APOLBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230364057-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. 2023-11-16 — — US disclosed
US-20230364057-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. 2023-11-16 — — US disclosed
US-20230136466-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2023-05-04 — — US disclosed
US-20230136466-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) 2023-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230364057-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF TOP1, DNA2, TOP2A MAPT 3260/4885MEN1 4457/4885KMT2A 2037/4885
US-20230136466-A1 BACTERIAL DNA GYRASE INHIBITORS AND METHODS OF USE THEREOF TOP1, DNA2, TOP2A MAPT 3260/4885MEN1 4457/4885KMT2A 2037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback